NeuroSense Therapeutics L... (NRSN)
NASDAQ: NRSN
· Real-Time Price · USD
1.20
0.03 (2.56%)
At close: Aug 15, 2025, 3:59 PM
1.20
0.42%
After-hours: Aug 15, 2025, 06:33 PM EDT
NeuroSense Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -10.21K | -10.19K | -7.25K | -11.62K | -10.11K | -9.63K | -13.41K | -11.67K | -10.49K | -9.29K | -7.18K | -4.63K | -4.04K | -5.04K | -5.26K | -4.64K |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.50 | 3.00 | 3.00 |
Stock-Based Compensation | 557.00 | 1.54K | 59.00 | 1.54K | 1.54K | 1.73K | 704.00 | 1.73K | 1.73K | 3.82K | 4K | 3.82K | 3.82K | 907.00 | 4.44K | 1.94K |
Other Working Capital | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 19.50 | 39.00 | 45.00 |
Other Non-Cash Items | 9.65K | 8.65K | 7.2K | 10.09K | 8.57K | 7.9K | 12.71K | 9.94K | 8.76K | 5.47K | 3.19K | 814.00 | 223.00 | 3.94K | 429.00 | 2.14K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 21.00 | 42.00 | 40.50 |
Operating Cash Flow | n/a | n/a | n/a | 1.78K | 1.78K | 6.89K | 4.08K | 5.11K | 5.11K | n/a | 2.81K | n/a | n/a | -170 | -340 | -517.5 |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.5 | -5 | -7 |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.5 | -5 | -7 |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | 3.69M | 3.69M | 3.69M | 3.69M | n/a | n/a | n/a | n/a | n/a | n/a | 254.00 |
Financial Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 254.00 |
Net Cash Flow | n/a | n/a | -2.33M | 3.4M | 1.22M | 362K | 2.75M | -2.97M | -790.19K | 64.81K | 2.81K | n/a | n/a | -172.5 | -345 | -270.5 |
Free Cash Flow | n/a | n/a | n/a | 1.78K | 1.78K | 6.89K | 4.08K | 5.11K | 5.11K | n/a | 2.81K | n/a | n/a | -172.5 | -345 | -524.5 |